Oska Health secures €11M to transform chronic care
Digital health startup Oska Health has raised a €11 million seed round to accelerate the rollout of its AI-driven platform for chronic disease management. The round is led by Belgian venture firm Capricorn Partners and SwissHealth Ventures, the investment arm of Swiss health insurer CSS, underscoring growing investor confidence in data-driven healthcare solutions.
Backing from strategic healthcare investors
The participation of SwissHealth Ventures, directly linked to major insurer CSS, positions Oska Health at the intersection of digital innovation and traditional healthcare systems. Strategic capital from an insurance-backed fund signals strong belief that technology-enabled care can reduce costs while improving outcomes for patients with long-term conditions.
Capricorn Partners, known for its focus on high-growth technology and life sciences companies, brings deep expertise in scaling European healthtech ventures. The new funding is expected to support product development, clinical validation and expansion into additional European markets.
AI-powered chronic disease management
Oska Health develops digital tools designed to support patients living with chronic illnesses, using AI algorithms and continuous data monitoring to personalize care. Its platform aims to detect early signs of deterioration, improve adherence to treatment plans and enable proactive interventions by clinicians.
By integrating patient-reported data, sensor inputs and medical records, the company’s technology targets conditions that place a heavy burden on healthcare systems, such as cardiovascular disease, diabetes and respiratory disorders. The goal is to shift from reactive hospital-based treatment to more efficient, home-centric and preventive care.
Scaling across European healthcare systems
The €11 million seed round will be used to grow Oska Health’s engineering and clinical teams, strengthen partnerships with insurers and healthcare providers, and pursue regulatory approvals where needed. The startup plans to demonstrate measurable reductions in hospitalizations and overall care costs, a key requirement for large-scale adoption within public and private health systems.
As European healthcare providers grapple with ageing populations, staff shortages and rising costs, investor interest in digital chronic care solutions is intensifying. With fresh capital and strong strategic backers, Oska Health is positioning itself as a key player in the next generation of technology-enabled chronic disease management.